Literature DB >> 7820573

Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer type.

D Aarsland1, J P Larsen, I Reinvang, A M Aasland.   

Abstract

To investigate the effect of cholinergic blockade on language, 22 healthy young women performed tests of reading, spelling and oral language after a subcutaneous injection of 0.4 or 0.6 mg scopolamine. The results were compared with the performance after 0.6 mg methylscopolamine, which produce no central cholinergic effects. The reading and spelling tests were constructed to evaluate the lexical and phonological strategies for reading and spelling of single words. After scopolamine there were dose-dependent impairments in reading, spelling, verbal fluency and object naming. In 25-60% of the subjects receiving 0.6 mg scopolamine there were clinically significant impairments on tests assessing the lexical and phonological strategies. This pattern is similar to the deficits in reading and spelling observed in patients with dementia of the Alzheimer type. Cholinergic loss may be associated with the language impairments found in dementia of the Alzheimer type.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7820573     DOI: 10.1093/brain/117.6.1377

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

1.  Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects.

Authors:  Bianca Voss; Renate Thienel; Martina Reske; Thilo Kellermann; Abigail J Sheldrick; Sarah Halfter; Katrin Radenbach; Nadim J Shah; Ute Habel; Tilo T J Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-10-18       Impact factor: 5.270

Review 2.  [Present status and future possibilities of adjuvant pharmacotherapy for aphasia].

Authors:  C Korsukewitz; C Breitenstein; M Schomacher; S Knecht
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

Review 3.  The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.

Authors:  A D Lawrence; B J Sahakian
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Psycholinguistics of Aphasia Pharmacotherapy: Asking the Right Questions.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Abigail Oveis
Journal:  Aphasiology       Date:  2014-01-01       Impact factor: 2.773

5.  The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.

Authors:  T Duka; H Ott; A Rohloff; B Voet
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

6.  Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade.

Authors:  Bianca Voss; Renate Thienel; Martina Reske; Ute Habel; Tilo Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-20       Impact factor: 5.270

7.  Neurophysiological predictors of long term response to AChE inhibitors in AD patients.

Authors:  V Di Lazzaro; A Oliviero; F Pilato; E Saturno; M Dileone; C Marra; S Ghirlanda; F Ranieri; G Gainotti; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

8.  Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.

Authors:  Scott E Counts; Shaoli Che; Stephen D Ginsberg; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2011-03-17       Impact factor: 3.052

Review 9.  Modes and models of forebrain cholinergic neuromodulation of cognition.

Authors:  Michael E Hasselmo; Martin Sarter
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

10.  Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus.

Authors:  Stefan J Teipel; Wilhelm Flatz; Nibal Ackl; Michel Grothe; Ingo Kilimann; Arun L W Bokde; Lea Grinberg; Edson Amaro; Vanja Kljajevic; Eduardo Alho; Christina Knels; Anne Ebert; Helmut Heinsen; Adrian Danek
Journal:  Psychiatry Res       Date:  2013-12-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.